• Issue
    2020
    i-ii, 1-341

FRONT COVER
Free Access

Front Cover, Volume 41, Issue 1

  • Page: i
  • First Published: 24 December 2019
Front Cover, Volume 41, Issue 1 Volume 41 Issue 1, 2020

Front Cover: The cover image is based on the Research Article TBX6 missense variants expand the mutational spectrum in a non-Mendelian inheritance disease by Weisheng Chen et al., https://doi.org/10.1002/humu.23907.

Cover image © Nan Wu Images.

INSIDE BACK COVER
Free Access

Inside Back Cover, Volume 41, Issue 1

  • Page: ii
  • First Published: 24 December 2019
Inside Back Cover, Volume 41, Issue 1 Volume 41 Issue 1, 2020

Inside Back Cover: The cover image is based on the Research Article Xq22 deletions and correlation with distinct neurological disease traits in females: Further evidence for a contiguous gene syndrome by Hadia Hijazi et al., https://doi.org/10.1002/humu.23902.

Cover image © Hadia Hijazi & Ameerah Deyab Images.

ISSUE INFORMATION
Free Access

Issue Information

  • Pages: 1-6
  • First Published: 24 December 2019

SPECIAL ARTICLE
Open Access

Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?

  • Pages: 7-16
  • First Published: 25 September 2019
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?

Participation to external quality assessment (EQA) improved compliance with Human Genome Variation Society (HGVS) recommendations. Compliance of variant descriptions was better for next-generation sequencing (20.9%) compared with targeted techniques (9.8%). A correct reference sequence was included for 36.0% of noncommercial versus 26.5% of commercial test methods. The residual percentage of noncompliance with HGVS suggests that laboratories, companies, and EQA providers need to collaborate for additional harmonization in clinical test reporting.

BRIEF REPORT
Full Access

Primary ciliary dyskinesia gene contribution in Tunisia: Identification of a major Mediterranean allele

  • Pages: 115-121
  • First Published: 30 August 2019
Primary ciliary dyskinesia gene contribution in Tunisia: Identification of a major Mediterranean allele

CCDC39 mutations are a major cause for primary ciliary dyskinesia in Tunisia (44% of independent cases). One CCDC39 founder mutation, c.2190del, is found in 24% of patients. This ancestral allele is identified in other Mediterranean patients and it is estimated to have arisen at least 1,400 years ago.

BRIEF REPORT
Open Access

Combined in vitro and in silico analyses of missense mutations in GNPTAB provide new insights into the molecular bases of mucolipidosis II and III alpha/beta

  • Pages: 133-139
  • First Published: 03 October 2019
Combined in vitro and in silico analyses of missense mutations in GNPTAB provide new insights into the molecular bases of mucolipidosis II and III alpha/beta
Graphical abstract

Mucolipidosis (ML) II and III alpha/beta are inherited lysosomal storage disorders caused by mutations in GNPTAB encoding the α/β-precursor of GlcNAc-1-phosphotransferase. In this study, we report on four disease-associated, highly conserved amino acid residues in the so-called stealth domains of the GlcNAc-1-phosphotransferase, which are strictly required for enzymatic activity and thus may be directly involved in the enzymatic catalysis.

RESEARCH ARTICLE
Open Access

A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically

  • Pages: 203-211
  • First Published: 06 September 2019
A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically

In next-generation sequencing (NGS) hereditary cancer panel testing, TP53 pathogenic variants whose NGS allele frequencies might appear consistent with those expected for germline variants, but the variant might be acquired somatically. Confirming TP53 variant origin can markedly impact medical management for tested individuals and their family members. The report highlights the need for a conservative approach to initial reporting of TP53-positive findings, along with investment in follow-up testing to deliver clinically accurate results.

RESEARCH ARTICLE
Full Access

Novel IQCE variations confirm its role in postaxial polydactyly and cause ciliary defect phenotype in zebrafish

  • Pages: 240-254
  • First Published: 24 September 2019
Novel IQCE variations confirm its role in postaxial polydactyly and cause ciliary defect phenotype in zebrafish

In this study, we report the confirmation of IQCE as a gene whose defects cause isolated postaxial polydactyly. Whole-exome sequencing has been applied to three families and revealed biallelic pathogenic variations in IQCE. Further functional analysis using the patient's cells (skin fibroblast) revealed no effect on the formation of the cilia but a mislocalization of the EVC2 and a defective hedgehog signaling. Zebrafish experiments demonstrated a full spectrum of phenotypes associated with defective cilia: Body curvature, kidney cysts, left–right asymmetry, misdirected cilia in the pronephric duct, and retinal defects.

RESEARCH ARTICLE
Open Access

Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants

  • Pages: 277-290
  • First Published: 28 September 2019
Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants

MYH9-related disorder diagnosis is still challenging in clinical practice. We analyzed the genetic variants in more than 3,000 patients with a bleeding or platelet disorder and identified 50 patients with a rare variant in MYH9. In the presence of an unclassified platelet disorder with macrothrombocytes, MYH9-RD should always be considered.

RESEARCH ARTICLE
Open Access

Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in neurofibromatosis type 1

Magdalena Koczkowska Tom Callens Yunjia Chen Alicia Gomes Alesha D. Hicks Angela Sharp Eric Johns Kim Armfield Uhas Linlea Armstrong Katherine Armstrong Bosanko Dusica Babovic-Vuksanovic Laura Baker Donald G. Basel Mario Bengala James T. Bennett Chelsea Chambers Lola K. Clarkson Maurizio Clementi Fanny M. Cortés Mitch Cunningham M. Daniela D'Agostino Martin B. Delatycki Maria C. Digilio Laura Dosa Silvia Esposito Stephanie Fox Mary-Louise Freckmann Christine Fauth Teresa Giugliano Sandra Giustini Allison Goetsch Yael Goldberg Robert S. Greenwood Cristin Griffis Karen W. Gripp Punita Gupta Eric Haan Rachel K. Hachen Tamara L. Haygarth Concepción Hernández-Chico Katelyn Hodge Robert J. Hopkin Louanne Hudgins Sandra Janssens Kory Keller Geraldine Kelly-Mancuso Aaina Kochhar Bruce R. Korf Andrea M. Lewis Jan Liebelt Angie Lichty Robert H. Listernick Michael J. Lyons Isabelle Maystadt Mayra Martinez Ojeda Carey McDougall Lesley K. McGregor Daniela Melis Nancy Mendelsohn Malgorzata J.M. Nowaczyk June Ortenberg Karin Panzer John G. Pappas Mary Ella Pierpont Giulio Piluso Valentina Pinna Eniko K. Pivnick Dinel A. Pond Cynthia M. Powell Caleb Rogers Noa Ruhrman Shahar S. Lane Rutledge Veronica Saletti Sarah A. Sandaradura Claudia Santoro Ulrich A. Schatz Allison Schreiber Daryl A. Scott Elizabeth A. Sellars Ruth Sheffer Elizabeth Siqveland John M. Slopis Rosemarie Smith Alberto Spalice David W. Stockton Haley Streff Amy Theos Gail E. Tomlinson Grace Tran Pamela L. Trapane Eva Trevisson Nicole J. Ullrich Jenneke Van den Ende Samantha A. Schrier Vergano Stephanie E. Wallace Michael F. Wangler David D. Weaver Kaleb H. Yohay Elaine Zackai Jonathan Zonana Vickie Zurcher Kathleen B. M. Claes Marica Eoli Yolanda Martin Katharina Wimmer Alessandro De Luca Eric Legius Ludwine M. Messiaen
  • Pages: 299-315
  • First Published: 08 October 2019